WASHINGTON (Reuters) - A 30-year-old Abbott Laboratories Inc. drug for attention deficit disorder poses an unacceptable risk of deadly liver damage and should be banned immediately, a U.S. consumer group said on Thursday.
Abbott sells the drug under the brand name Cylert, and generic companies sell a copycat version known as pemoline.
Public Citizen said the drug had caused 21 cases of liver failure, including 13 that were fatal or required transplants.
Britain and Canada have pulled the drug off the market, while the U.S. Food and Drug Administration (news - web sites) has opted to strengthen warnings twice and allow sales to continue, Public Citizen said.
Full Story
_________________
UncoverTheNews.com - No News is NOT Good NewsListen to The Jack Blood Show @ American Freedom Radio Monday - Friday 10:00 am EST
"If liberty means anything at all, it means the right to tell people what they do not want to hear." ~ George Orwell
Login
Register
FAQ
Search
